Reconsolidation-Based Intervention for Traumatic Memories
The Effect and Underlying Mechanism of Reconsolidation-Based Cognitive Reappraisal for Traumatic Memories in Patients With Major Depression Disorder
1 other identifier
interventional
390
0 countries
N/A
Brief Summary
The goal of this clinical trial is to test the effect and underlying mechanism of reconsolidation-based cognitive reappraisal for traumatic memories in patients with major depression disorder. The main questions it aims to answer are:
- Is cognitive reappraisal based on memory reconsolidation effective for laboratory-created traumatic memories? Which of the two classical cognitive reassessment schemes is more effective?
- What is the neural mechanism by which the novel cognitive reappraisal based on memory reconsolidation alters traumatic memories?
- Can repeated use of the novel cognitive reappraisal based on memory reconsolidation alter the actual childhood traumatic memories of patients with major depression disorder? Can it reduce depressive symptoms? Are the effects long-lasting? Participants will be grouped to receive the intervention (retrieval + cognitive reappraisal, non-retrieval + cognitive reappraisal). The researchers will compare the differences in long-term memory tests and the improvement in depressive symptoms between the two groups to see the effects of the memory-based reconsolidation intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Dec 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2023
CompletedFirst Posted
Study publicly available on registry
November 22, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedNovember 22, 2023
November 1, 2023
1.8 years
October 31, 2023
November 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in Participants' Skin Conductance Response (SCR)
The level of SCR was assessed for each trial as the base-to-peak amplitudedifference in skin conductance of the largest deflection (in microsiemens; pS) in the 0.5-4.5-slatency window after stimulus onset.
baseline, 8 weeks, and one year after treatment
Change in the amygdala measured with fMRI
Changes in the difference in BOLD (Blood Oxygenation Level Dependent) signal in the amygdala between treated cue and untreated cue measured with fMRI.
baseline, 8 weeks, and one year after treatment
Change in the hippocampus measured with fMRI
Changes in the difference in BOLD (Blood Oxygenation Level Dependent) signal in the hippocampus between treated cue and untreated cue measured with fMRI.
baseline, 8 weeks, and one year after treatment
Change in the prefrontal cortex measured with fMRI
Changes in the difference in BOLD (Blood Oxygenation Level Dependent) signal in the prefrontal cortex between treated cue and untreated cue measured with fMRI
baseline, 8 weeks, and one year after treatment
Secondary Outcomes (3)
The changes in the Baker Depression Scale (BDI).
baseline, 8 weeks, and one year after treatment
The changes in the State-Trait Anxiety Scale (STAI)
baseline, 8 weeks, and one year after treatment
The changes in the GROSS Self-Rating Emotional Regulation Style Questionnaire
baseline, 8 weeks, and one year after treatment
Study Arms (4)
retrieval + self-focused cognitive reappraisal
EXPERIMENTALParticipants in this arm will first accept a memory reactivation to open the reconsolidation window, then accept the self-focused cognitive reappraisal intervention.
retrieval + context-focused cognitive reappraisal
EXPERIMENTALParticipants in this arm will first accept a memory reactivation to open the reconsolidation window, then accept the context-focused cognitive reappraisal.
non-retrieval + self-focused cognitive reappraisal
ACTIVE COMPARATORParticipants in this arm will directly accept the self-focused cognitive reappraisal intervention without memory reactivation.
non-retrieval + context-focused cognitive reappraisal
ACTIVE COMPARATORParticipants in this arm will directly accept the context-focused cognitive reappraisal intervention without memory reactivation.
Interventions
During the retrieval phase, cues are presented to participants to reactivate their memories; participants in the non-retrieval group go directly to cognitive reappraisal phase.
Subsequently, in the self-focused cognitive reappraisal group, participants will be instructed to use "disengagement" reappraisal to separate themselves from the picture situation and draw a subjective distance so as not to strongly feel the negative emotions brought by the picture. In the context-focused reappraisal group, participants will focus on the picture situation, reappraise the meaning of the picture situation, and assign positive meanings to it.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of major depression disorder
- Must have normal vision or corrected vision
You may not qualify if:
- Have physical diseases or other mental disorders
- Be pregnant, breastfeeding or do not have menstruation
- Drink alcohol or smoke within 24 hours before the experiment
- Participated in similar experiments before.
- History of severe cardiovascular and cerebrovascular diseases, stroke and other neurological diseases, and history of digestive system diseases.
- Severe hearing and vision impairment.
- Have metal implants in the body, such as non-removable dentures, scaffolds, steel plates, joint metal replacements, etc.
- Have Claustrophobia
- Have acute or chronic disease or infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jingchu Hu, Dr.
Shenzhen Kangning Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 31, 2023
First Posted
November 22, 2023
Study Start
December 1, 2023
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
November 22, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- These information will be shared after the related paper is published and will be available for at least one year
- Access Criteria
- The information will be shared on the Open Science Framework for the public
We wiil share our data on the Open Science Framework after data collection